Company intelligence / Profile preview

Euroclone Diagnostica

Pero, Lombardy, Italy

Ownership: Private
Employees: ~96
Development stage: Other

Overview

Euroclone develops and commercializes molecular diagnostic assays for detecting emerging sexually transmitted pathogens and provides comprehensive life science products and services for research and clinical diagnostics.

Therapeutic areas: HematologyOncologyRare DiseasesInfectious Diseases
Modalities: Molecular diagnostic assaysRecombinant protein
Industry: Molecular Diagnostics

Partnerships

BD (Becton, Dickinson and Company)

Beyond the preview

Go deeper on Euroclone Diagnostica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Euroclone Diagnostica.

Explore the full profile